The influence of adjuvant chemotherapy dose intensity on overall survival in resected colon cancer: a multicentered retrospective analysis

BACKGROUND: Colorectal cancer remains the second leading cause of cancer death in North America. Fluorouracil and oxaliplatin based adjuvant chemotherapy for resected colon cancer (CC) reduces cancer recurrence, but also causes significant toxicity requiring dose reductions. The effect of dose inten...

Descripción completa

Detalles Bibliográficos
Autores principales: Breadner, Daniel, Loree, Jonathan M., Cheung, Winson Y., Gipson, Meghan, Lakkunarajah, Suganija, Mulder, Karen E., Spartlin, Jennifer L., Kong, Shiying, Ding, Philip Q., Gill, Sharlene, Welch, Stephen A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628061/
https://www.ncbi.nlm.nih.gov/pubmed/36319973
http://dx.doi.org/10.1186/s12885-022-10198-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9628061/
https://www.ncbi.nlm.nih.gov/pubmed/36319973
http://dx.doi.org/10.1186/s12885-022-10198-y

Ejemplares similares